InSitu Biologics, Inc.
OperatingBiotech · Oakdale, MN
Financials
FY2017–FY2019 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Cap table
Principal holders% as the filing states it, Sep 17, 2020
- Linda Pavek Trust766,445 Class A Common Shares13.0%of Class A
- Mary Karl Trust766,445 Class A Common Shares13.0%of Class A
- Gerard & Ellen Lavery617,956 Class A Common Shares10.0%of Class A
- James & Kathryn Knapp308,978 Class A Common Shares5%of Class A
- William Taylor250,290 Class A Common Shares4%of Class A
Sold to the crowd
- Reg A+ · Jun 20181,960,998 shares at $2.00 in today's terms · sold as 980,499 Common Stock at $4.00; since then a 2-for-1 split (Feb 2019)$3.9M
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
3 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 30 filings on EDGAR- Form DAug 10, 20260001723443-26-000005EDGAR
- Form DDec 18, 20250001723443-25-000003EDGAR
- Form DDec 29, 20230001790300-23-000004EDGAR
- Form DFeb 25, 20210001790300-21-000002EDGAR
- Form 1-ZDec 30, 20200001437749-20-026146EDGAR
- Form 1-KSep 17, 20200001477932-20-005441EDGAR
- Form 1-UMay 1, 20200001477932-20-002332EDGAR
- Form 253G2Oct 21, 20190001477932-19-005974EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.